Actively Recruiting
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Led by Tianjin Medical University · Updated on 2023-06-23
15
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis
CONDITIONS
Official Title
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients voluntarily participate in studies and sign informed consent forms
- Ages 2 to 80 years, male or female
- Patients with cytomegalovirus retinitis after hematopoietic stem cell transplantation or cord blood transplantation, with white blood cell count less than 4 x 10^9/L and platelet count between 25 x 10^9/L and less than 100 x 10^9/L, unable to use systemic medication or intravitreal injection due to infection and bleeding risks
- Patients with cytomegalovirus retinitis with AIDS, CD4+ T cell count less than 100/µl, with high infection risk from intravitreal injection and unable to control severe CMV retinitis with systemic medication
You will not qualify if you...
- Presence of refractive interstitial opacification affecting fundus observation
- Intravitreal ganciclovir or sodium phosphonate injections within 1 week prior to baseline
- Other eye diseases affecting visual function such as syphilis-related eye diseases, acute retinal necrosis, congenital glaucoma, congenital corneal lesions, congenital macular degeneration
- Severe neutropenia (less than 0.5 x 10^9) or severe thrombocytopenia (less than 25 x 10^9/L)
- Other conditions judged by investigators as unsuitable for enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China, 300000
Actively Recruiting
Research Team
X
xiaomin Zhang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here